| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MEDP | Common Stock | Sale | -$40M | -100K | -1.86% | $400.32 | 5.29M | Feb 23, 2024 | Direct | F1, F2 |
| transaction | MEDP | Common Stock | Sale | -$22.9M | -56.9K | -1.08% | $402.38 | 5.23M | Feb 26, 2024 | Direct | F1, F3 |
| Id | Content |
|---|---|
| F1 | The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period. |
| F2 | The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $396.15 to $402.50. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request. |
| F3 | The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $397.98 to $405.72. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request. |